221 articles
Maze Therapeutics' MZE829 reduced kidney damage markers by over 35% in patients with APOL1-mediated kidney disease in Phase 2 trials.
New study of 96,000 people shows brief bursts of intense activity dramatically reduce risks of heart disease, dementia, and diabetes.
Stanford-Buck coalition develops intrinsic capacity score to quantify aging and test interventions through YMCA partnerships.
New research reveals how tumors reprogram neutrophils to produce CCL3, turning immune defenders into cancer allies.
WHO-commissioned reviews find Ozempic and similar drugs deliver up to 16% weight loss, but long-term safety data remains limited.
Scientists discover nerve fibers create a self-sustaining loop that accelerates pancreatic cancer development before tumors even form.
Analysis of 123,940 patients reveals most reported statin side effects occur equally in placebo groups, challenging widespread medication fears.
Researchers identify N4BP2, the enzyme behind chromothripsis - a genetic catastrophe that helps one in four cancers rapidly evolve and resist treatment.
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.
Northwestern researchers dramatically boosted cancer vaccine effectiveness by simply repositioning one protein fragment on their nanovaccine.
Researchers found 260,000 cancer-specific RNAs that act as molecular fingerprints and can be detected through simple blood tests.
Three existing drugs, including a shingles vaccine, emerge as top candidates for repurposing against Alzheimer's disease.
